Klinikum der Universität München (Großhadern und Innenstadt)

Bispecific antibodies redirect synthetic agonistic receptor modified T cells against melanoma (2023) Maerkl F, Benmebarek MR, Keyl J, Cadilha BL, Geiger M, Karches C, Obeck H, et al. Journal article HDAC2 is involved in the regulation of Brn3a in melanocytes and melanoma (2023) Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf S, Besch R, French LE, et al. Conference contribution Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis (2023) Kreuter M, Bonella F, Blank N, Riemekasten G, Mueller-Ladner U, Henes J, Siegert E, et al. Journal article Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock (2023) Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, Dauw J, et al. Journal article Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study (2022) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Journal article Expression of nectin-4 in papillary renal cell carcinoma (2022) Zschabitz S, Mikuteit M, Stoehr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry (2022) Blank N, Schmalzing M, Moinzadeh P, Oberste M, Siegert E, Mueller-Ladner U, Riemekasten G, et al. Journal article Sequential treatment patterns over time for advanced renal cell carcinoma: data from the German research platform CARAT (2022) Goebell P, Gruellich C, Mueller L, Boegemann M, Martens U, Von Der Heyde E, Reichert D, et al. Conference contribution HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia (2022) Baron F, Labopin M, Tischer J, Ciceri F, Raiola AM, Blaise D, Sica S, et al. Conference contribution Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/ Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis (2022) Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhaeuser M, Stelljes M, Finke J, et al. Journal article